Search

everythinglearnresearchcommunity

for

Search:↓

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Some drugs used to treat immune conditions may cause different types of hair loss.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Biologics for severe asthma have known side effects, but some new risks need more study.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

The document lists various dermatology topics, treatments, and diagnostic methods.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Finasteride improved hidradenitis suppurativa in kids without side effects.

The document concludes that while "hair follicle cloning" shows promise for unlimited donor hair, it faces challenges with consistency and safety in humans.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Adalimumab can cause complete hair loss in rare cases.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Adipose-derived stem cells show promise in treating skin conditions like vitiligo, alopecia, and nonhealing wounds.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.